Biomarkers in Infection

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Beth Israel Deaconess Medical Center
Study ID
NCT02545478
Status
Recruiting
Apply to this trial

Conditions

  • Infection
  • Inflammation
  • Sepsis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.

Key Dates

Start date
Apr 30, 2006
Status verified
Apr 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2031

Study Design

Enrollment
4,200 participants (estimated)

Arms

  • Arm: Infected Group
    subjects with suspected infection
  • Arm: Non-infected group
    subjects without any infection

Primary Outcome Measure

28 day in-hospital mortality [ Time Frame: within 28 days after inclusion ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Nathan Shapiro, MD MPH
[email protected]
617-754-2343
Massachusetts General HospitalBostonMassachusetts02114-

Find similar trials in Boston, MA

By research site
Beth Israel Deaconess Medical Center· Boston, MAMassachusetts General Hospital· Boston, MA

Related Studies